CELSUS THERAPEUTICS Trademark

Trademark Overview


On Tuesday, February 26, 2013, a trademark application was filed for CELSUS THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the CELSUS THERAPEUTICS trademark a serial number of 85860190. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 2, 2015. This trademark is owned by Morria Biopharmaceuticals Plc. The CELSUS THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products and preparations for treating disease, namely, obstructive respiratory disease, asthma, inflammatory and anti-viral diseases, colitis, Crohn's disease, central nervous system insult, multiple sclerosis, contact dermatitis, psoriasis, cardiovascular disease, invasive cellular proliferative disorders, allergic rhinitis, cystic fibrosis, inflammatory disease of the skin, ophthalmologic diseases, hemolytic syndromes, sepsis, acute respiratory distress syndrome, tissue transplant rejection syndromes, autoimmune disease, viral infection, osteoarthritis and hypersensitivity conjunctivitis; pharmaceuticals for use as a coating for cardiovascular stents and other stents; coating treatments, namely, pharmaceutical preparations used to coat devices for the prevention of inflammatory reactions as a result of invasive procedures; anti-oxidants supplements; pharmaceutical preparations, namely, anti-inflammatories and analgesics
celsus therapeutics

General Information


Serial Number85860190
Word MarkCELSUS THERAPEUTICS
Filing DateTuesday, February 26, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 2, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 6, 2013

Trademark Statements


Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and ServicesPharmaceutical products and preparations for treating disease, namely, obstructive respiratory disease, asthma, inflammatory and anti-viral diseases, colitis, Crohn's disease, central nervous system insult, multiple sclerosis, contact dermatitis, psoriasis, cardiovascular disease, invasive cellular proliferative disorders, allergic rhinitis, cystic fibrosis, inflammatory disease of the skin, ophthalmologic diseases, hemolytic syndromes, sepsis, acute respiratory distress syndrome, tissue transplant rejection syndromes, autoimmune disease, viral infection, osteoarthritis and hypersensitivity conjunctivitis; pharmaceuticals for use as a coating for cardiovascular stents and other stents; coating treatments, namely, pharmaceutical preparations used to coat devices for the prevention of inflammatory reactions as a result of invasive procedures; anti-oxidants supplements; pharmaceutical preparations, namely, anti-inflammatories and analgesics

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 4, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCelsus Therapeutics Plc
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressLondon W1K5JH
GB

Party NameMorria Biopharmaceuticals Plc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLondon W1K5JH
GB

Party NameMorria Biopharmaceuticals Plc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLondon W1K5JH
GB

Trademark Events


Event DateEvent Description
Monday, November 2, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, November 2, 2015ABANDONMENT - NO USE STATEMENT FILED
Wednesday, April 1, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 31, 2015EXTENSION 3 GRANTED
Tuesday, March 24, 2015EXTENSION 3 FILED
Tuesday, March 24, 2015TEAS EXTENSION RECEIVED
Thursday, October 2, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 1, 2014EXTENSION 2 GRANTED
Monday, September 29, 2014EXTENSION 2 FILED
Monday, September 29, 2014TEAS EXTENSION RECEIVED
Wednesday, April 2, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 1, 2014EXTENSION 1 GRANTED
Monday, March 3, 2014EXTENSION 1 FILED
Friday, March 28, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 3, 2014TEAS EXTENSION RECEIVED
Wednesday, October 2, 2013REVIEW OF CORRESPONDENCE COMPLETE
Tuesday, October 1, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 24, 2013ASSIGNED TO PETITION STAFF
Monday, September 9, 2013TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, August 28, 2013ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, August 6, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 6, 2013PUBLISHED FOR OPPOSITION
Wednesday, July 17, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, July 1, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, June 26, 2013ASSIGNED TO LIE
Monday, June 10, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 10, 2013EXAMINER'S AMENDMENT ENTERED
Monday, June 10, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, June 10, 2013EXAMINERS AMENDMENT E-MAILED
Monday, June 10, 2013EXAMINERS AMENDMENT -WRITTEN
Monday, June 10, 2013ASSIGNED TO EXAMINER
Monday, March 4, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, March 1, 2013NEW APPLICATION ENTERED IN TRAM